innoscripta SE (ETR:1INN)
Germany · Delayed Price · Currency is EUR 75.50
+3.10 (4.28%)
At close: Aug 3, 2026
innoscripta SE Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 118.14 | 103.59 | 65.06 | 39.28 | 26.37 | 19.99 | |
Revenue Growth | 49.78% | 59.21% | 65.65% | 48.94% | 31.93% | 122.78% |
Cost of Revenue | 4.73 | 4.12 | 1.81 | 1.3 | 0.67 | - |
Gross Profit | 113.41 | 99.47 | 63.26 | 37.98 | 25.7 | 19.99 |
Selling, General & Admin | 23.98 | 26.25 | 17.97 | 16.79 | 11.72 | 1.9 |
Depreciation & Amortization Expenses | 0.23 | 0.2 | 0.18 | 0.15 | 0.15 | 0 |
Other Operating Expenses | 10.98 | 9.6 | 7.83 | 5.57 | 4.65 | -4.23 |
Total Operating Expenses | 35.19 | 36.04 | 25.98 | 22.51 | 16.52 | -2.33 |
Operating Income | 78.22 | 63.42 | 37.28 | 15.47 | 9.18 | 22.32 |
Interest Income | 0.34 | 0.21 | 0.23 | 0.06 | 0.12 | 0.01 |
Interest Expense | -0.12 | -0.05 | -0.09 | -0.08 | -0.06 | 0.21 |
Other Non-Operating Income (Expense) | 0 | - | - | - | - | - |
Total Non-Operating Income (Expense) | 0.21 | 0.17 | 0.14 | -0.02 | 0.07 | 0.22 |
Pretax Income | 78.43 | 63.59 | 37.42 | 15.45 | 9.25 | 22.54 |
Provision for Income Taxes | 24.56 | 20.98 | 12.33 | 5.18 | 3.15 | -2.55 |
Net Income | 50.06 | 42.61 | 25.09 | 10.27 | 6.1 | 4.99 |
Minority Interest in Earnings | - | 0 | 1.09 | 0.5 | 5 | - |
Net Income to Common | 50.06 | 42.61 | 24 | 9.77 | 1.1 | 4.99 |
Net Income Growth | 53.17% | 77.55% | 145.58% | 790.54% | -78.00% | 1595.11% |
Shares Outstanding (Basic) | 10 | 10 | 10 | 5 | 0 | - |
Shares Outstanding (Diluted) | 10 | 10 | 10 | 5 | 0 | - |
Shares Change | - | 4.61% | 91.21% | 19900.00% | - | - |
EPS (Basic) | 5.01 | 4.26 | 2.51 | 1.95 | 43.89 | - |
EPS (Diluted) | 5.01 | 4.26 | 2.51 | 1.95 | 43.89 | - |
EPS Growth | 53.17% | 69.72% | 28.43% | -95.55% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 49.08 | 40.64 | 20 | 5.15 | 0 | 0 |
Free Cash Flow Growth | 57.10% | 103.21% | 288.44% | - | - | - |
Free Cash Flow Per Share | 4.91 | 4.06 | 2.09 | 1.03 | - | - |
Dividends Per Share | 4.000 | 4.000 | 2.400 | 1.600 | 200.000 | - |
Dividend Growth | 66.67% | 66.67% | 50.00% | -99.20% | - | - |
Gross Margin | 96.00% | 96.02% | 97.22% | 96.69% | 97.45% | 100.00% |
Operating Margin | 66.21% | 61.23% | 57.29% | 39.39% | 34.80% | 111.63% |
Profit Margin | 42.38% | 41.13% | 38.56% | 26.15% | 23.12% | 24.95% |
FCF Margin | 41.54% | 39.23% | 30.74% | 13.11% | 0.00% | 0.00% |
EBITDA | 78.45 | 63.62 | 37.46 | 15.62 | 9.18 | 22.32 |
EBITDA Margin | 66.40% | 61.41% | 57.57% | 39.77% | 34.80% | 111.63% |
EBIT | 78.22 | 63.42 | 37.28 | 15.47 | 9.18 | 22.32 |
EBIT Margin | 66.21% | 61.23% | 57.29% | 39.39% | 34.80% | 111.63% |
Effective Tax Rate | 31.31% | 33.00% | 32.94% | 33.52% | 34.05% | -11.30% |